The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Transplantation of Cryopreserved Human Embryonal Carcinoma-Derived Neurons (NT2N Cells) Promotes Functional Recovery in Ischemic Rats
Open accessAbstract
This study was designed to explore the efficacy of a human clone cell line as an alternative neural graft source and to validate the practice of cryopreservation and xenografting as logistical approaches toward conducting neural transplantation. We investigated the biological effects of transplanting cultured human neurons (NT2N cells) derived from a well-characterized embryonal carcinoma cell line into the brains of rats subjected to transient, focal cerebral ischemia induced by embolic occlusion of the middle cerebral artery. At 1 month and extending throughout the 6-month posttransplantation test period, ischemic animals that were transplanted with NT2N cells and treated with an immunosuppressive drug displayed a significant improvement in a passive avoidance task as well as a normalization of asymmetrical motor behavior compared to ischemic animals that received rat fetal cerebellar cell grafts or vehicle alone. Remarkably, cryopreserved NT2N cell grafts compared with fresh NT2N cell grafts, remained viable in the immunosuppressed rat brain and effective in producing behavioral recovery in immunosuppressed ischemic animals. The long-term viability of cryopreserved NT2N cell xenografts in vivo and their sustained effectiveness in promoting behavioral recovery suggest potential utilization of xenografting and cryopreservation as useful protocols for establishing clone cell lines as graft source in neural transplantation therapies for central nervous system disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
A neostriatal habit learning system in humans
Knowlton, B. J., Mangels, J. A., & Squire, L. R. (1996) · Science · doi:10.1126/science.273.5280.1399 · Cited by 1,777
Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's Disease
Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D., et al. (1990) · Science · doi:10.1126/science.2105529 · Cited by 1,207
Experimental studies of ischemic brain edema
Koizumi, J.-I., Yoshida, Y., Nakazawa, T., & Ooneda, G. (1986) · Nosotchu · doi:10.3995/jstroke.8.1 · Cited by 996
Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System
Perlow, M. J., Freed, W. J., Hoffer, B. J., Seiger, A., Olson, L., & Wyatt, R. J. (1979) · Science · doi:10.1126/science.571147 · Cited by 966
Kordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J. G., Mufson, E. J., Sanberg, P. R., Hauser, R. A., Smith, D. A., Nauert, G. M., Perl, D. P., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321702 · Cited by 860
Self-citationReconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants
Bjo¨rklund, A., & Stenevi, U. (1979) · Brain Research · doi:10.1016/0006-8993(79)90472-4 · Cited by 830
Isolation, Characterization, and use of Stem Cells from the CNS
Gage, F. H., Ray, J., & Fisher, L. J. (1995) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.18.030195.001111 · Cited by 829
Koizumi, J. (1986) · Medical Entomology and Zoology · Cited by 762
Cited by
Cell replacement therapies for central nervous system disorders
Björklund, A., & Lindvall, O. (2000) · Nature Neuroscience · doi:10.1038/75705 · Cited by 934
Zhao, L.-R., Duan, W.-M., Reyes, M., Keene, C. D., Verfaillie, C. M., & Low, W. C. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7853 · Cited by 823
Flax, J. D., Aurora, S., Yang, C., Simonin, C., Wills, A. M., Billinghurst, L. L., Jendoubi, M., Sidman, R. L., Wolfe, J. H., Kim, S. U., et al. (1998) · Nature Biotechnology · doi:10.1038/3473 · Cited by 770
Transplantation of cultured human neuronal cells for patients with stroke
Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K. R., Gebel, J., Jannetta, P., DeCesare, S., Elder, E. M., McGrogan, M., et al. (2000) · Neurology · doi:10.1212/wnl.55.4.565 · Cited by 629
Kelly, S., Bliss, T. M., Shah, A. K., Sun, G. H., Ma, M., Foo, W. C., Masel, J., Yenari, M. A., Weissman, I. L., Uchida, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404474101 · Cited by 614
Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial
Kondziolka, D., Steinberg, G. K., Wechsler, L., Meltzer, C. C., Elder, E., Gebel, J., DeCesare, S., Jovin, T., Zafonte, R., Lebowitz, J., et al. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.1.0038 · Cited by 451
Borlongan, C. V., Hadman, M., Davis Sanberg, C., & Sanberg, P. R. (2004) · Stroke · doi:10.1161/01.str.0000141680.49960.d7 · Cited by 439
Self-citationStem cell‐based cell therapy in neurological diseases: A review
Kim, S. U., & de Vellis, J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22054 · Cited by 426
Walczak, P., Zhang, J., Gilad, A. A., Kedziorek, D. A., Ruiz-Cabello, J., Young, R. G., Pittenger, M. F., van Zijl, P. C. M., Huang, J., & Bulte, J. W. M. (2008) · Stroke · doi:10.1161/strokeaha.107.502047 · Cited by 405
Cell transplantation therapy for stroke
Bliss, T., Guzman, R., Daadi, M., & Steinberg, G. K. (2007) · Stroke · doi:10.1161/01.str.0000247888.25985.62 · Cited by 374
Jeong, S.-W., Chu, K., Jung, K.-H., Kim, S. U., Kim, M., & Roh, J.-K. (2003) · Stroke · doi:10.1161/01.str.0000083698.20199.1f · Cited by 366
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., Lu, M., Raginski, K., Vanguri, P., Smith, A., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600311 · Cited by 353
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
Alexi, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00032-5 · Cited by 295
Intravenous versus intrastriatal cord blood administration in a rodent model of stroke
Willing, A. E., Lixian, J., Milliken, M., Poulos, S., Zigova, T., Song, S., Hart, C., Sanchez‐Ramos, J., & Sanberg, P. R. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10659 · Cited by 294
Self-citationPollock, K., Stroemer, P., Patel, S., Stevanato, L., Hope, A., Miljan, E., Dong, Z., Hodges, H., Price, J., & Sinden, J. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.011 · Cited by 277
From teratocarcinomas to embryonic stem cells
Andrews, P. W. (2002) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1058 · Cited by 264
Akt Contributes to Neuroprotection by Hypothermia against Cerebral Ischemia in Rats
Zhao, H., Shimohata, T., Wang, J. Q., Sun, G., Schaal, D. W., Sapolsky, R. M., & Steinberg, G. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3163-05.2005 · Cited by 263
Horie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., Shamloo, M., Hamilton, S. A., Jiang, K., Huhn, S., et al. (2011) · Stem Cells · doi:10.1002/stem.584 · Cited by 240
Neural stem/precursor cells for the treatment of ischemic stroke
Bacigaluppi, M., Pluchino, S., Martino, G., Kilic, E., & Hermann, D. M. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.012 · Cited by 111
Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke
HARA, K., YASUHARA, T., MAKI, M., MATSUKAWA, N., MASUDA, T., YU, S., ALI, M., YU, G., XU, L., & KIM, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.005 · Cited by 85
Metadata
- Authors
- Borlongan, C. V., Tajima, Y., Trojanowski, J. Q., Lee, V. M.-Y., & Sanberg, P. R.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 149
- Issue
- 2
- Pages
- 310-321
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2012359897
- Cited by
- 357
- References
- 48
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.